STRS Ohio’s Integra LifeSciences IART Stock Holding History

STRS Ohio’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,100	Closed	-$378K	–	2236
2026 Q1	$378K	Hold	40,100	–	–	﹤0.01%	1228
2025 Q4	$498K	Sell	40,100 -8,800	-18%	-$117K	﹤0.01%	1093
2025 Q3	$701K	Sell	48,900 -3,100	-6%	-$42.5K	﹤0.01%	837
2025 Q2	$638K	Buy	52,000 +33,800	+186%	+$491K	﹤0.01%	1101
2025 Q1	$400K	Hold	18,200	–	–	﹤0.01%	1298
2024 Q4	$413K	Hold	18,200	–	–	﹤0.01%	1273
2024 Q3	$331K	Buy	18,200 +17,000	+1,417%	+$394K	﹤0.01%	1418
2024 Q2	$35K	Buy	+1,200	New	+$35.6K	﹤0.01%	1834
2023 Q4	–	Sell	-41,730	Closed	-$1.59M	–	1955
2023 Q3	$1.59M	Buy	41,730 +2,679	+7%	+$113K	0.01%	700
2023 Q2	$1.61M	Buy	39,051 +10,972	+39%	+$528K	0.01%	719
2023 Q1	$1.61M	Buy	28,079 +1,047	+4%	+$59K	0.01%	735
2022 Q4	$1.51M	Sell	27,032 -811	-3%	-$41.3K	0.01%	758
2022 Q3	$1.18M	Sell	27,843 -92,049	-77%	-$4.72M	0.01%	804
2022 Q2	$6.48M	Buy	119,892 +30,193	+34%	+$1.81M	0.03%	433
2022 Q1	$5.76M	Buy	89,699 +5,280	+6%	+$348K	0.02%	483
2021 Q4	$5.66M	Sell	84,419 -2,947	-3%	-$199K	0.02%	483
2021 Q3	$5.98M	Buy	87,366 +1,449	+2%	+$102K	0.02%	474
2021 Q2	$5.86M	Buy	85,917 +7,895	+10%	+$558K	0.02%	481
2021 Q1	$5.39M	Sell	78,022 -2,341	-3%	-$159K	0.02%	484
2020 Q4	$5.22M	Sell	80,363 -15,247	-16%	-$820K	0.02%	468
2020 Q3	$4.51M	Buy	95,610 +3,064	+3%	+$146K	0.02%	470
2020 Q2	$4.35M	Buy	92,546 +77,278	+506%	+$3.8M	0.02%	456
2020 Q1	$682K	Buy	15,268 +617	+4%	+$32.4K	﹤0.01%	918
2019 Q4	$853K	Buy	14,651 +9,432	+181%	+$561K	﹤0.01%	1028
2019 Q3	$313K	Buy	+5,219	New	+$311K	﹤0.01%	1514
2019 Q1	–	Sell	-7,187	Closed	-$324K	–	2071
2018 Q4	$324K	Buy	7,187 +498	+7%	+$27.3K	﹤0.01%	1473
2018 Q3	$440K	Buy	6,689 +606	+10%	+$37.7K	﹤0.01%	1441
2018 Q2	$391K	Sell	6,083 -1,017	-14%	-$63K	﹤0.01%	1488
2018 Q1	$392K	Buy	7,100 +1,000	+16%	+$52.4K	﹤0.01%	1378
2017 Q4	$291K	Sell	6,100 -900	-13%	-$44.1K	﹤0.01%	1439
2017 Q3	$353K	Sell	7,000 -700	-9%	-$36K	﹤0.01%	1443
2017 Q2	$419K	Buy	7,700 +2,900	+60%	+$138K	﹤0.01%	1377
2017 Q1	$202K	Hold	4,800	–	–	﹤0.01%	1532
2016 Q4	$205K	Sell	4,800 -1,600	-25%	-$65K	﹤0.01%	1550
2016 Q3	$264K	Buy	6,400 +600	+10%	+$25.1K	﹤0.01%	1488
2016 Q2	$231K	Buy	5,800 +3,000	+107%	+$108K	﹤0.01%	1518
2016 Q1	$94K	Buy	2,800 +1,000	+56%	+$31.1K	﹤0.01%	1676
2015 Q4	$61K	Buy	1,800 +400	+29%	+$12.5K	﹤0.01%	1761
2015 Q3	$41K	Buy	+1,400	New	+$43.8K	﹤0.01%	1776

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

STRS Ohio's IART Position: Q2 2026 in Review

STRS Ohio sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 40,100 shares — an estimated $378K sold.

STRS Ohio first reported a position in IART in Q3 2015 and held it in 39 quarters. The position peaked at $6.48M in Q2 2022. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

STRS Ohio reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
STRS Ohio sold 40,100 Integra LifeSciences shares in Q2 2026, an estimated $378K.
STRS Ohio first reported a position in Integra LifeSciences in Q3 2015 and held it in 39 quarters.
STRS Ohio's Integra LifeSciences position peaked at $6.48M in Q2 2022.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.